Primary |
Diabetes Mellitus |
27.9% |
Hypertension |
20.9% |
Glucose Tolerance Impaired |
9.4% |
Cardiovascular Disorder |
8.2% |
Type 2 Diabetes Mellitus |
6.6% |
Diabetes Mellitus Non-insulin-dependent |
6.1% |
Osteoarthritis |
2.9% |
Coagulopathy |
2.0% |
Gastrooesophageal Reflux Disease |
2.0% |
Hyperlipidaemia |
2.0% |
Coronary Artery Disease |
1.6% |
Renal Transplant |
1.6% |
Convulsion |
1.2% |
Cystitis |
1.2% |
Prophylaxis |
1.2% |
Rash |
1.2% |
Urinary Retention |
1.2% |
Arrhythmia |
0.8% |
Blood Glucose Increased |
0.8% |
Chronic Obstructive Pulmonary Disease |
0.8% |
|
Death |
15.7% |
Thrombocytopenia |
10.0% |
Vomiting |
8.6% |
Weight Increased |
7.1% |
Syncope |
5.7% |
Weight Decreased |
5.7% |
Blood Glucose Abnormal |
4.3% |
Dizziness |
4.3% |
Eye Haemorrhage |
4.3% |
Hypoglycaemic Coma |
4.3% |
Renal Artery Stenosis |
4.3% |
Abdominal Pain Upper |
2.9% |
Cardiac Arrest |
2.9% |
Catheter Placement |
2.9% |
Cerebrovascular Accident |
2.9% |
Chest Pain |
2.9% |
Drug Ineffective |
2.9% |
Hepatic Steatosis |
2.9% |
Hyperglycaemia |
2.9% |
Hypoglycaemia |
2.9% |
|
Secondary |
Glucose Tolerance Impaired |
39.1% |
Cardiovascular Disorder |
19.1% |
Diabetes Mellitus |
12.6% |
Hypertension |
9.8% |
Diabetes Mellitus Non-insulin-dependent |
3.5% |
Type 2 Diabetes Mellitus |
2.5% |
Coagulopathy |
1.2% |
Drug Use For Unknown Indication |
1.2% |
Product Used For Unknown Indication |
1.2% |
Anxiety |
1.1% |
Hypothyroidism |
1.1% |
Pain |
1.1% |
Rash |
1.1% |
Cystitis |
0.9% |
Prophylaxis |
0.9% |
Urinary Retention |
0.9% |
Arthralgia |
0.7% |
Cardiovascular Event Prophylaxis |
0.7% |
Hot Flush |
0.7% |
Ischaemic Cardiomyopathy |
0.7% |
|
Tinnitus |
20.9% |
Vomiting |
12.7% |
Weight Decreased |
9.0% |
Surgery |
6.0% |
Ventricular Tachycardia |
6.0% |
Pancreatitis Acute |
5.2% |
Syncope |
4.5% |
Glycosylated Haemoglobin Increased |
3.7% |
Stress |
3.7% |
Thrombocytopenia |
3.7% |
Pelvic Fracture |
3.0% |
Skin Irritation |
3.0% |
Weight Increased |
3.0% |
White Blood Cell Count Increased |
3.0% |
Wound Abscess |
3.0% |
Death |
2.2% |
Disease Progression |
2.2% |
Tremor |
2.2% |
Dyspnoea |
1.5% |
Fall |
1.5% |
|
Concomitant |
Product Used For Unknown Indication |
23.6% |
Drug Use For Unknown Indication |
21.4% |
Diabetes Mellitus |
11.5% |
Type 2 Diabetes Mellitus |
10.2% |
Diabetes Mellitus Non-insulin-dependent |
9.9% |
Hypertension |
4.4% |
Nuclear Magnetic Resonance Imaging |
2.6% |
Pain |
2.3% |
Depression |
2.3% |
Hiv Infection |
2.1% |
Blood Cholesterol Increased |
1.5% |
Coronary Artery Disease |
1.1% |
Blood Pressure |
1.0% |
Multiple Myeloma |
0.9% |
Angiogram |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Asthma |
0.8% |
Cardiac Failure Congestive |
0.8% |
Osteoporosis |
0.8% |
Rheumatoid Arthritis |
0.8% |
|
Weight Decreased |
26.8% |
Myocardial Infarction |
9.4% |
Vomiting |
9.4% |
Blood Glucose Increased |
8.7% |
Nausea |
8.2% |
Weight Increased |
6.1% |
Pain |
4.3% |
Pneumonia |
3.0% |
Myocardial Ischaemia |
2.5% |
Urinary Tract Infection |
2.5% |
Transient Ischaemic Attack |
2.3% |
Pancreatitis |
2.2% |
Tremor |
2.2% |
Pain In Extremity |
2.1% |
Cerebrovascular Accident |
2.0% |
Oedema Peripheral |
1.8% |
Injection Site Pain |
1.7% |
Type 2 Diabetes Mellitus |
1.7% |
Coronary Artery Disease |
1.6% |
Death |
1.4% |
|